What was recalled
This page synthesizes the structural framework around pea protein and other pulse-derived protein concentrates in pet food. Pea protein concentrate is produced by separating the protein fraction from yellow or green peas through wet or dry processing, yielding 75-85% protein dry matter. Pea protein isolate is a further-refined fraction yielding 85-95% protein. Chickpea protein, lentil protein, fava bean protein, and other pulse-derived protein concentrates follow analogous extraction processes. These ingredients contribute substantial crude protein on the AAFCO Guaranteed Analysis at a fraction of the cost of named-species animal protein meal.
The use pattern in commercial pet food expanded substantially during the grain-free formulation trend (2010-2020). Grain-free formulations replaced traditional carbohydrate sources (rice, oats, barley) with legumes (peas, lentils, chickpeas) and other pulse ingredients. To maintain or exceed traditional Guaranteed Analysis protein levels (24-30% for dogs, 30-40% for cats), the formulations relied on multiple pulse ingredients with extracted protein concentrates. The FDA Center for Veterinary Medicine opened its grain-free DCM investigation in 2018 after a cluster of taurine-deficient dilated cardiomyopathy cases appeared in atypical breeds eating pulse-heavy grain-free formulations. The investigation tracked 515+ cases reports through 2022 across multiple grain-free brands.
Why it was recalled
The structural controversy is whether pea protein and pulse-derived protein concentrates contribute equivalent nutritional value to the named-species animal protein ingredients they partially replace. Biological value (BV) measures the proportion of absorbed protein retained for tissue maintenance and growth. Animal-source protein (chicken meal BV ~75-80, egg BV ~94) generally exceeds plant-source protein (pea protein BV ~60-65, soy protein BV ~70-75). The amino acid completeness profile differs as well: animal-source protein typically meets all 10 essential amino acids for dogs and the 11 essential amino acids for cats; plant-source proteins are typically deficient in one or more essential amino acids and require complementary protein sourcing or synthetic amino acid supplementation to meet AAFCO Nutrient Profiles.
The taurine availability question raised by the FDA DCM investigation is more specific. Taurine is a conditionally essential amino acid for dogs (synthesizable from methionine and cysteine in adequate quantity) and absolutely essential for cats. Pulse-heavy formulations may interfere with taurine bioavailability through multiple mechanisms: (1) reduced animal-source protein content reduces the methionine and cysteine substrate for taurine synthesis; (2) some pulse ingredients (specifically legumes containing tannins, saponins, and antinutritional factors) may bind taurine in the gut, reducing absorption; (3) the gut microbiome shift caused by high-pulse diets may convert taurine to other metabolites. The FDA DCM investigation page documents the case series and investigation methodology. The investigation closed inconclusively but the FDA continues to monitor the pattern.
Health risks for your pet
The documented health risk profile from pulse-heavy grain-free formulations is centered on taurine-deficient dilated cardiomyopathy (DCM) in dogs. DCM is a serious cardiac condition characterized by enlargement and weakening of the heart muscle, reduced cardiac output, congestive heart failure, and increased mortality. Traditional genetic-predisposition breeds for DCM include Doberman Pinschers, Great Danes, Irish Wolfhounds, and Boxers. The FDA DCM investigation 2018-2023 identified case clusters in atypical breeds (Golden Retrievers, Labradors, mixed-breed dogs) eating pulse-heavy grain-free formulations, suggesting a diet-induced rather than genetic-induced mechanism. Cases reported through the investigation included documented hospitalizations and deaths.
For dogs already diagnosed with DCM associated with diet, dietary change (transition to legume-free, named-meat-source formulations with adequate taurine) plus veterinary cardiac management has produced documented cases of cardiac function improvement and DCM reversal — supporting the diet-induced mechanism for the atypical-breed case cluster. The pattern reinforces the structural concern: when pea protein and pulse-derived protein concentrates contribute substantial portions of the Guaranteed Analysis protein content, the formulation’s biological-value protein and taurine substrate adequacy may be compromised in ways the on-label Guaranteed Analysis does not communicate.
What to do if you bought affected product
Pet owners feeding grain-free or pulse-heavy formulations can manage the structural risk through: (1) ingredient deck inspection — look for pea protein, pea protein concentrate, pea flour, lentil protein, chickpea protein, or multiple pulse ingredients in the top 5-10 positions on the ingredient deck; if multiple pulses appear, the formulation is pulse-heavy; (2) named-species meat positioning — verify that named-species meat or meat meal appears in the top 2-3 positions and that the formulation is not driven primarily by pulse protein; (3) taurine supplementation — some grain-free brands have added taurine supplementation post-2018 in response to the FDA investigation; verify taurine is listed in the ingredient deck for grain-free formulations; (4) breed-risk awareness — Golden Retrievers, Doberman Pinschers, Cocker Spaniels, and known DCM-susceptible breeds should not be fed pulse-heavy grain-free formulations without veterinary nutritionist consultation. Cats are obligate carnivores with different taurine metabolism; grain-free cat food does not carry the same DCM risk pattern but pulse-heavy cat food still raises biological-value protein adequacy concerns.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 weights named-species animal-source protein favorably and penalizes pulse-derived protein concentrates (pea protein, pea protein concentrate, pea flour, lentil protein, chickpea protein) when they contribute substantially to formulation protein content per our published methodology. The scoring weight differential reflects the biological-value protein, amino acid completeness, and taurine substrate adequacy advantage of animal-source protein. Grain-free formulations are scored on their full ingredient deck composition; pulse-heavy grain-free formulations receive lower scoring than grain-inclusive formulations with equivalent named-species meat content. The grain-free DCM controversy page covers the broader FDA investigation context.